LAT software induced savings on medical costs of alcohol addicts' care - Results from a matched-pairs case-control study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Jakovljevic, Mihajlo ^a   Jovanovic, Mirjana ^a   Rancic, Nemanja ^b   Vyssoki, Benjamin ^c   Djordjevic, Natasa ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; COST CONTROL; FEMALE; HEALTH PROGRAM; HOSPITAL CARE; HOSPITAL COST; HUMAN; LESCH ALCOHOLISM TYPOLOGY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHARMACEUTICAL CARE; PSYCHOTHERAPY; RETROSPECTIVE STUDY; SERBIA; MEDICAL INFORMATICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ALCOHOLISM; CASE-CONTROL STUDIES; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MEDICAL INFORMATICS; MIDDLE AGED; RETROSPECTIVE STUDIES; SOFTWARE;

EID: 84915820516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111931     Document Type: Article

References (38)

1. Shield KD, Rylett M, Gmel G, Gmel G, Kehoe-Chan TA, et al. (2013) Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the comparative risk assessment for the 2010 Global Burden of Disease Study. Addiction 108: 912-922.
2. Ando B, Rozsa S, Kurgyis E, Szkaliczki A, Demeter I, et al. (2013) Direct and Indirect Symptom Severity Indicators of Alcohol Dependence and the Personality Concept of the Biosocial Model. Subst Use Misuse.
3. Chisholm D, Rehm J, Van Ommeren M, Monteiro M (2004) Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol 65: 782-793.
4. Neighbors CJ, Barnett NP, Rohsenow DJ, Colby SM, Monti PM (2010) Costeffectiveness of a motivational intervention for alcohol-involved youth in a hospital emergency department. J Stud Alcohol Drugs 71: 384-394.
5. Wutzke SE, Shiell A, Gomel MK, Conigrave KM (2001) Cost effectiveness of brief interventions for reducing alcohol consumption. Soc Sci Med 52: 863-870.
6. Palmer AJ, Neeser K, Weiss C, Brandt A, Comte S, et al. (2000) The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol Alcohol 35: 478-492.
7. Rychlik R, Siedentop H, Pfeil T, Daniel D (2003) Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients. Eur Addict Res 9: 59-64.
8. Walters D, Connor JP, Feeney GF, Young RM (2009) The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence. J Addict Dis 28: 137-144.
9. Jakovljevic M, Jovanovic M, Lazic Z, Jakovljevic V, Djukic A, et al. (2011) Current efforts and proposals to reduce healthcare costs in Serbia. Ser J Exp Clin Res 12: 161-163.
10. Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, et al. (2013) Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis 56: 430-446.
11. Drozda JP (2013) Physician specialty society clinical guidelines and bending the cost curve: comment on "Cost consideration in the clinical guidance documents of physician specialty societies in the United States". JAMA Intern Med 173: 1097-1099.
12. French MT, Salome HJ, Sindelar JL, McLellan AT (2002) Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Serv Res 37: 433-455.
13. Picon PD, Beltrame A, Banta D (2013) National guidelines for high-cost drugs in Brazil: achievements and constraints of an innovative national evidence-based public health policy. Int J Technol Assess Health Care 29: 198-206.
14. Babor TF, Dolinsky ZS, Meyer RE, Hesselbrock M, Hofmann M, et al. (1992) Types of alcoholics: concurrent and predictive validity of some common classification schemes. Br J Addict 87: 1415-1431.
15. Cloninger CR, Bohman M, Sigvardsson S (1981) Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch Gen Psychiatry 38: 861-868.
16. Lesch WC, Celuch KG (1991) Females' use of alcoholic beverages: a study in context. J Health Soc Policy 2: 23-38.
17. Lesch OM, Walter H (1996) Subtypes of alcoholism and their role in therapy. Alcohol Alcohol Suppl 1: 63-67.
18. Bleich S, Bayerlein K, Reulbach U, Hillemacher T, Bonsch D, et al. (2004) Homocysteine levels in patients classified according to Lesch's typology. Alcohol Alcohol 39: 493-498.
19. Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, et al. (2005) Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 11: 83-91.
20. Leggio L, Kenna GA, Fenton M, Bonenfant E, Swift RM (2009) Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev 19: 115-129.
21. Lesch OM, Walter H, Wetschka C, Hesselbrock M, Hesselbrock V (2011) Alcohol and tobacco. Medical and sociological aspects of use, abuse and addiction. Vienna, Austria, Springer-Verlag.
22. Jakovljevic M, Rankovic A, Rancic N, Jovanovic M, Ivanovic M, et al. (2013) Radiology services costs and utilization patterns estimates in Southeastern Europe - a retrospective analysis from Serbia. Value in health regional issues 2: 218-225.
23. Jakovljevic MB (2013) Resource allocation strategies in Southeastern European health policy. Eur J Health Econ 14: 153-159.
24. Jovanovic M, Jakovljevic M (2011) Inpatient detoxification procedure and facilities: financing considerations from an Eastern European perspective. Alcohol Alcohol 46: 364-365.
25. Jakovljevic M, Jovanovic M, Nikic K, Radovanovic A, Pirkovic I, et al. (2011) Inpatient detoxification and law enforcement costs following acute drinking event, in typical eastern European upper - middle income, health care setting. Health Behavior & Public Health 1: 1-7.
26. Pedrero Perez E, Rojo Mota G (2008) [Personality differences between substance addicts and general population. Study of clinical cases with matched controls using Cloninger's TCI-R]. Adicciones 20: 251-261. Spanish.
27. Westermeyer J, Specker S (1999) Social resources and social function in comorbid eating and substance disorder: a matched-pairs study. Am J Addict 8: 332-336.
28. Johnson RS, Tobin JW, Cellucci T (1992) Personality characteristics of cocaine and alcohol abusers: more alike than different. Addict Behav 17: 159-166.
29. Westermeyer J, Peng G (1977) Opium and heroin addicts in Laos. II. A study of matched pairs. J Nerv Ment Dis 164: 351-354.
30. Stockwell T (1998) Towards guidelines for low-risk drinking: quantifying the short- and long-term costs of hazardous alcohol consumption. Alcohol Clin Exp Res 22: 63S-69S.
31. Caputo F, Del Re A, Brambilla R, Grignaschi A, Vignoli T et al. (2014). Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study. Journal of Psychopharmacology, 28(1), 23-30.
32. Djordjevic ND, Jankovic SM (2006) Characteristics of decision-making process during prescribing in general practice. Vojnosanit Pregl 63: 279-285.
33. Rankovic A, Rancic N, Jovanovic M, Ivanovic M, Gajovic O, et al. (2013) Impact of imaging diagnostics on the budget-are we spending too much? Vojnosanit Pregl 70: 709-711.
34. Jakovljevic M, Vukovic M, Chia-Ching C, Yamada T, Antunovic M, et al. (2013) Do policy measures impact cost consciousness of healthcare professionals? Value in Health 16: A542, doi:10.1016/j.jval.2013.08.1376.
35. Haas L, Stargardt T, Schreyoegg J, Schlosser R, Klapp BF, et al. (2013) The trade-off between costs and quality of care in the treatment of psychosomatic patients with somatoform pain disorder. Appl Health Econ Health Policy 11: 359-368.
36. Jakovljevic M, Riegler A, Jovanovic M, Djordjevic N, Patek K, et al. (2013) Serbian and Austrian alcohol-dependent patients: a comparison of two samples regarding therapeutically relevant clinical features. Alcohol Alcohol 48: 505-508.
37. Hussey AM, Koch G, Preisser JS, Saville RB (2013) Analysis of matched studies with dichotomous outcomes using nonparametric randomization-based analysis of covariance. Statistics in Biopharmaceutical Research, 5.
38. Zweifel P (2012) The Grossman model after 40 years. Eur J Health Econ 13: 677-682.